Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

An effective human immunodeficiency virus type 1 (HIV-1) vaccine must induce protective antibody responses, as well as CD4(+) and CD8(+) T cell responses, that can be effective despite extraordinary diversity of HIV-1. The consensus and mosaic immunogens are complete but artificial proteins, computa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Hulot, Sandrine L., Korber, Bette, Giorgi, Elena E., Vandergrift, Nathan, Saunders, Kevin O., Balachandran, Harikrishnan, Mach, Linh V., Lifton, Michelle A., Pantaleo, Giuseppe, Tartaglia, Jim, Phogat, Sanjay, Jacobs, Bertram, Kibler, Karen, Perdiguero, Beatriz, Gomez, Carmen E., Esteban, Mariano, Rosati, Margherita, Felber, Barbara K., Pavlakis, George N., Parks, Robert, Lloyd, Krissey, Sutherland, Laura, Scearce, Richard, Letvin, Norman L., Seaman, Michael S., Alam, S. Munir, Montefiori, David, Liao, Hua-Xin, Haynes, Barton F., Santra, Sampa
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474309/
https://ncbi.nlm.nih.gov/pubmed/25855741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00383-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados